HCM
NVO

Hutchinson Capital Management’s Novo Nordisk NVO Stock Holding History

Hutchinson Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.15M Sell
194,428
-5,513
-3% -$261K 1.31% 27
2025
Q4 		$10.2M Buy
199,941
+546
+0.3% +$27.9K 1.74% 23
2025
Q3 		$11.1M Sell
199,395
-1,422
-0.7% -$83.2K 1.91% 24
2025
Q2 		$13.9M Buy
200,817
+13,949
+7% +$949K 2.53% 19
2025
Q1 		$13M Buy
186,868
+11,217
+6% +$926K 2.48% 18
2024
Q4 		$15.1M Buy
175,651
+563
+0.3% +$60.9K 2.85% 13
2024
Q3 		$20.8M Sell
175,088
-886
-0.5% -$118K 3.95% 7
2024
Q2 		$25.1M Buy
175,974
+384
+0.2% +$50.9K 5.14% 5
2024
Q1 		$22.5M Buy
175,590
+734
+0.4% +$87.4K 4.56% 7
2023
Q4 		$18.1M Sell
174,856
-137
-0.1% -$13.5K 3.94% 8
2023
Q3 		$15.9M Sell
174,993
-1,477
-0.8% -$130K 3.74% 9
2023
Q2 		$14.3M Sell
176,470
-54,984
-24% -$4.49M 3.35% 10
2023
Q1 		$18.4M Buy
231,454
+1,236
+0.5% +$87.6K 4.78% 7
2022
Q4 		$15.6M Sell
230,218
-2,816
-1% -$165K 4.02% 10
2022
Q3 		$11.6M Buy
233,034
+986
+0.4% +$52.8K 3.15% 16
2022
Q2 		$12.9M Buy
232,048
+1,654
+0.7% +$91.8K 3.35% 17
2022
Q1 		$12.8M Sell
230,394
-2,646
-1% -$136K 2.98% 15
2021
Q4 		$13.1M Buy
233,040
+120
+0.1% +$6.5K 2.9% 17
2021
Q3 		$11.2M Buy
232,920
+332
+0.1% +$16.1K 2.7% 19
2021
Q2 		$9.74M Sell
232,588
-103,776
-31% -$4.02M 2.42% 19
2021
Q1 		$11.3M Sell
336,364
-6,886
-2% -$245K 2.83% 21
2020
Q4 		$12M Sell
343,250
-16,742
-5% -$579K 3.12% 18
2020
Q3 		$12.5M Sell
359,992
-15,310
-4% -$510K 3.72% 13
2020
Q2 		$12.3M Sell
375,302
-7,096
-2% -$226K 3.82% 11
2020
Q1 		$11.5M Sell
382,398
-5,326
-1% -$159K 3.81% 11
2019
Q4 		$11.2M Sell
387,724
-2,592
-0.7% -$71.8K 2.94% 15
2019
Q3 		$10.1M Sell
390,316
-6,336
-2% -$160K 2.73% 14
2019
Q2 		$10.1M Sell
396,652
-7,342
-2% -$181K 2.85% 14
2019
Q1 		$10.6M Sell
403,994
-344,330
-46% -$8.46M 3.18% 11
2018
Q4 		$17.2M Buy
748,324
+51,476
+7% +$1.14M 5.76% 2
2018
Q3 		$16.4M Buy
696,848
+5,900
+0.9% +$144K 4.57% 5
2018
Q2 		$15.9M Sell
690,948
-9,330
-1% -$222K 4.95% 4
2018
Q1 		$17.2M Sell
700,278
-309,774
-31% -$8.13M 5.01% 9
2017
Q4 		$27.1M Sell
1,010,052
-8,560
-0.8% -$218K 7.03% 1
2017
Q3 		$24.5M Buy
1,018,612
+4,816
+0.5% +$109K 6.62% 1
2017
Q2 		$21.7M Buy
1,013,796
+8,162
+0.8% +$165K 6.16% 3
2017
Q1 		$17.2M Buy
1,005,634
+499,504
+99% +$8.7M 4.76% 10
2016
Q4 		$9.07M Buy
+506,130
New +$9.18M 2.49% 22

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Hutchinson Capital Management's NVO Position: Q1 2026 in Review

Hutchinson Capital Management reduced its Novo Nordisk (NVO) stake by 2.8% in Q1 2026, selling an estimated $261K and leaving 194,428 shares worth $7.15M. The position accounts for 1.31% of the portfolio, ranked #27.

Hutchinson Capital Management first reported a position in NVO in Q4 2016 and has held it in 38 quarters since. The position peaked at $27.1M in Q4 2017. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Hutchinson Capital Management held 194,428 shares of Novo Nordisk worth $7.15M as of Q1 2026.
  • Hutchinson Capital Management sold 5,513 Novo Nordisk shares in Q1 2026, an estimated $261K.
  • Novo Nordisk made up 1.31% of Hutchinson Capital Management's portfolio in Q1 2026, its #27 holding.
  • Hutchinson Capital Management first reported a position in Novo Nordisk in Q4 2016 and has held it in 38 quarters since.
  • Hutchinson Capital Management's Novo Nordisk position peaked at $27.1M in Q4 2017.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Hutchinson Capital Management's 13F filing for Q1 2026, filed 12 May 2026.